Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Name (Synonyms) | Correlation | |
---|---|---|
drug2477 | Physical exercise training Wiki | 1.00 |
drug771 | Ciclesonide Wiki | 0.71 |
drug2490 | Placebo Wiki | 0.05 |
Name (Synonyms) | Correlation | |
---|---|---|
HP:0001626 | Abnormality of the cardiovascular system HPO | 0.17 |
Navigate: Correlations HPO
There is one clinical trial.
COVEPICARDIO trial is designed to document the effects of remote monitoring of physical exercise and home-based cognitive training on cognitive and physical functions in older adults with cardiovascular diseases.
Description: Validated remote version of Montreal Cognitive Assessment
Measure: Change in general cognitive functioning Time: Baseline and post-intervention at 6 monthsDescription: Validated remote version of Rey auditory verbal learning test, Trail Making Test, as well as Phonological and Semantic Fluency, Similarity, and Digit Span neuropsychological tests and iPad tests (Composite Z-score).
Measure: Change in executive functions Time: Baseline and post-intervention at 6 months.Description: Validated remote version of Rey auditory verbal learning test, Trail Making Test, as well as Phonological and Semantic Fluency, Similarity, and Digit Span neuropsychological tests and iPad tests (Composite Z-score).
Measure: Change in processing speed Time: Baseline and post-intervention at 6 monthsDescription: Validated remote version of Rey auditory verbal learning test, Trail Making Test, as well as Phonological and Semantic Fluency, Similarity, and Digit Span neuropsychological tests and iPad tests (Composite Z-score).
Measure: Change in episodic memory Time: Baseline and post-intervention at 6 monthsDescription: 4-meter walking test (m/s).
Measure: Change in Walking speed Time: Baseline and post-intervention at 6 months.Description: Timed up and Go test (s).
Measure: Change in Functional mobility Time: Baseline and post-intervention at 6 monthsDescription: Timed one-leg standing test (s)
Measure: Change in Balance performance Time: Baseline and post-intervention at 6 monthsDescription: Timed Sit-to-Stand test (s).
Measure: Change in Lower limb muscles strength Time: Baseline and post-intervention at 6 monthsDescription: Matthews cardiorespiratory fitness questionnaire (the score is an estimation of individual VO2 max (ml.kg.min) and range from 15-50, with a higher score indicating a higher VO2max)
Measure: Change in Cardiorespiratory fitness Time: Baseline and post-intervention at 6 monthsDescription: 36-Item Short Form Health Survey (Scale ranges from 0-100, with a higher score indicating a better health status).
Measure: Change in Quality-of-life Time: Baseline and post-intervention at 6 months.Description: Geriatric Depression Scale questionnaire (Score ranges from 0-30, with a higher score indicating larger depressive symptomatology).
Measure: Change in Depressive symptomatology Time: Baseline and post-intervention at 6 months.Description: State-Trait Anxiety Inventory questionnaire (Score ranges from 20-80, with a higher score indicating higher anxiety)
Measure: Change in Anxiety Time: Baseline and post-intervention at 6 months.Description: Perceived Stress Scale questionnaire (Score ranges from 0-4, with 0 no stress,1 mild stress, 3 moderate stress and 4 severe)
Measure: Change in Perceived stress Time: Baseline and post-intervention at 6 months.Description: Perseverative thinking questionnaire (Score ranges from 0-60, with a higher score indicating more repetitive negative thinking)
Measure: Change in Repetitive negative thinking Time: Baseline and post-intervention at 6 months.Description: Connor-Davidson Resilience Scale 10 questionnaire (Score ranges from 0-40, with a higher indicating better the resilience)
Measure: Change in Self-perceived resilience Time: Baseline and post-intervention at 6 months.Description: Lubben Social Network Scale questionnaire (Score ranges from 0-30, with a higher score indicating more social engagement).
Measure: Change in Perceived social support Time: Baseline and post-intervention at 6 months.Description: Social and community involvement questionnaire (Score ranges from 0-200, with a higher score indicating more social and community involvement).
Measure: Change in Social and community activities involvement Time: Baseline and post-intervention at 6 months.Description: Physical Activity Scale for the Elderly questionnaire (Score ranges from 0-400, with a higher score indicating better level of physical activity).
Measure: Change in Self-reported physical activity Time: Baseline and post-intervention at 6 months.Description: Pittsburg Sleep Quality Index questionnaire (Score ranges from 0-21, with a higher score indicating worse sleep quality)
Measure: Change in Sleep quality Time: Baseline and post-intervention at 6 months.Description: Berlin Questionnaire (Participants are classified into High Risk or Low Risk based on their responses to the individual items and their overall scores in the symptom categories.High Risk: if there are 2 or more categories where the score is positive. Low Risk: if there is only 1 or no categories where the score is positive).
Measure: Change in Risk of sleep apnea Time: Baseline and post-intervention at 6 months.Description: Short Diet Questionnaire (Score ranges from 15-45 points, with a score between 15-29 categorised as unhealthy, 30-37 as somewhat unhealthy, and 38 or more as a healthy diet).
Measure: Dietary patterns Time: BaselineDescription: Intolerance of Uncertainty scale questionnaire (Score ranges from 27-135, with a higher score indicating higher intolerance of uncertainty).
Measure: Intolerance of Uncertainty Time: BaselineDescription: Anxiety Sensitivity Index questionnaire (Score ranges from 0-64, with a higher score indicating a higher sensitivity to anxiety)
Measure: Anxiety Sensitivity Time: BaselineDescription: Perceived vulnerability to disease questionnaire (Score ranges from 15-95, with a higher score indicating a higher perceived vulnerability to disease).
Measure: Perceived vulnerability to disease Time: BaselineDescription: Rami and colleagues' cognitive reserve questionnaire (Scale ranges from 0-26, with a higher score indicating a greater cognitive reserve).
Measure: Cognitive Reserve Time: BaselineDescription: Short Form Bem Sex-Role Inventory questionnaire (30 items questionnaire with 10 items assessing the femininity traits, 10 items assessing the masculinity traits, and 10 items neutral, not scored. Two scores are calculated for femininity and masculinity, respectively, and range from 10-70, whit a higher score indicating a higher femininity or masculinity trait).
Measure: Self-reported masculinity and femininity traits Time: BaselineAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports